MEDIFAST (MED)
(Delayed Data from NYSE)
$19.53 USD
+0.69 (3.66%)
Updated Jul 25, 2024 03:52 PM ET
After-Market: $19.50 -0.03 (-0.15%) 5:02 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MED 19.53 +0.69(3.66%)
Will MED be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MED
Medifast (MED) Lags Industry in 3 Months: How to Play Ahead?
Medifast (MED) Tumbles More Than 40% in 3 Months: Here's Why
MED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Medifast (MED) Q1 Earnings Miss Estimates, Revenues Fall Y/Y
Medifast's (MED) Transformation on Track Amid Macro Headwinds
MEDIFAST (MED) Down 11.5% Since Last Earnings Report: Can It Rebound?
Other News for MED
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024
Time to Unload: 3 Stocks in Deep Trouble to Sell Now
70 All Star And Graham Value Stocks: 56 Fit To Buy In July
D.A. Davidson Sticks to Its Sell Rating for Medifast (MED)
7 Consumer Staples Stocks to Buy at a 52-Week Low in July